A Radiologist’s Guide to T1 Hyperintensity, T2 Signal, Enhancement, DWI/ADC, Differential Diagnosis, Staging, and Multidisciplinary Management

A patient in his 50s presented with persistent nasal obstruction. At first glance, such a symptom can easily be attributed to rhinitis, chronic sinus disease, or a nasal polyp. Yet imaging revealed something fundamentally different: a soft-tissue mass centered in the left nasal cavity with extension toward the left maxillary and ethmoid sinuses. MRI demonstrated heterogeneous signal characteristics, enhancement, and diffusion restriction. Histopathologic examination ultimately established the diagnosis of sinonasal melanoma.

This case illustrates an important principle in head and neck imaging: a common symptom does not necessarily indicate a common disease.

Sinonasal mucosal melanoma is rare, but it is clinically important because symptoms are often nonspecific and the tumor can extend silently through anatomically complex spaces before diagnosis. The sinonasal cavity is immediately adjacent to the orbit, skull base, cranial nerves, major vessels, and intracranial structures. Consequently, the radiologist's responsibility extends beyond identifying a mass. The radiologist must determine where the tumor began, how it spreads, whether its MRI signal suggests melanin, whether there is true diffusion restriction, and which critical structures are involved.

The most useful imaging clue in melanotic sinonasal melanoma is often an unexpectedly high signal on T1-weighted MRI. However, T1 hyperintensity is not synonymous with melanoma. Hemorrhage, proteinaceous material, fat, and other substances can also produce high T1 signal. Therefore, the correct diagnostic approach is not to recognize a single sign in isolation but to integrate the entire imaging phenotype.

Executive Clinical Summary

This case concerns a man in his 50s with nasal obstruction who underwent facial MRI. The examination demonstrated a left nasal cavity mass extending into the left maxillary and ethmoid sinuses. The lesion showed heterogeneous T1 and T2 signal characteristics, enhancement, and diffusion restriction. Histopathology confirmed sinonasal melanoma.

From a radiologic perspective, five findings deserve particular attention:

Unilateral nasal cavity-centered mass
T1 hyperintensity suggesting a possible melanotic component
Variable T2 signal
Contrast enhancement
True diffusion restriction supported by high DWI signal and low ADC

The combination is considerably more informative than any individual sequence.

Key Clinical Questions

What should raise suspicion for sinonasal melanoma?

Persistent unilateral nasal obstruction, recurrent epistaxis, a visible nasal mass, or progressive sinonasal symptoms—particularly in middle-aged or older adults—should prompt careful evaluation rather than repeated treatment as uncomplicated inflammatory disease.

What is the classic MRI clue?

T1 hyperintensity within a sinonasal mass can suggest the presence of melanin because melanin has paramagnetic properties that can shorten T1 relaxation.

Does every sinonasal melanoma appear T1 hyperintense?

No. Amelanotic melanoma may lack the characteristic T1 hyperintensity. Therefore, absence of T1 hyperintensity does not exclude the diagnosis.

Is DWI useful?

Yes. Diffusion restriction can provide additional information, particularly when conventional MRI findings are considered together with ADC measurements.

Can MRI establish the diagnosis by itself?

No. Imaging can strongly suggest the diagnosis and define tumor extent, but definitive diagnosis requires histopathologic evaluation.

Introduction: The Diagnostic Trap of a Common Symptom

Nasal obstruction is one of the most common symptoms encountered in otolaryngology and primary care. In most patients, the explanation is benign: allergic rhinitis, chronic rhinosinusitis, septal deviation, turbinate hypertrophy, or nasal polyposis.

The diagnostic challenge begins when a common symptom persists, becomes unilateral, or is accompanied by recurrent epistaxis or a visible mass.

Sinonasal mucosal melanoma is sufficiently rare that it may not be the first diagnosis considered clinically. Yet rarity should not prevent recognition when the imaging pattern is suggestive.

The anatomy of the sinonasal tract partly explains why diagnosis can be delayed. A tumor can grow within a relatively capacious anatomical region before producing dramatic symptoms. Once symptoms become obvious, the lesion may already involve adjacent compartments.

The case presented here demonstrates why MRI interpretation should not stop at the question, "Is there a mass?"

The more important questions are:

Where did the mass originate?
What structures has it crossed?
Is there evidence of melanin?
Is there hemorrhage or another cause of T1 shortening?
Does the lesion truly restrict diffusion?
Does the pattern favor melanoma over squamous cell carcinoma or another sinonasal malignancy?
What does the imaging imply for local staging and treatment planning?

Learning Objectives

By the end of this article, readers should be able to:

Recognize the major clinical and MRI clues associated with sinonasal melanoma.
Explain why melanin can produce T1 hyperintensity.
Interpret T2, contrast-enhanced MRI, DWI, and ADC findings in the context of sinonasal melanoma.
Distinguish sinonasal melanoma from important imaging differentials such as squamous cell carcinoma, esthesioneuroblastoma, and lymphoma.
Understand the complementary roles of CT and MRI in local staging.
Appreciate the limitations of imaging and the necessity of histopathologic confirmation.

Anatomy: Why the Sinonasal Region Is So Difficult

The sinonasal tract is not a simple cavity. It is a three-dimensional anatomical network composed of the nasal cavity and multiple paranasal sinuses, surrounded by critical structures.

For tumor assessment, the radiologist should systematically evaluate:

Nasal cavity
Nasal septum
Ethmoid air cells
Maxillary sinus
Frontal sinus
Sphenoid sinus
Orbital medial wall
Skull base
Nasopharynx
Pterygopalatine fossa
Perineural pathways
Adjacent vascular structures

The clinical importance of these relationships is substantial.

A tumor that remains confined to the nasal cavity has a different surgical problem from one that extends through the ethmoid region toward the orbit or skull base.

Thus, tumor size alone is an inadequate description of disease severity.

Anatomical relationships determine resectability, surgical complexity, and local staging.

Case Presentation

Patient Profile

The patient was a man in his 50s who presented with nasal obstruction.

Clinical Presentation

The principal symptom was nasal obstruction. The source material emphasizes that unilateral obstruction and recurrent epistaxis can be deceptively nonspecific and may initially resemble inflammatory sinonasal disease.

Imaging

Facial MRI demonstrated a soft-tissue mass centered in the left nasal cavity with extension toward the left maxillary and ethmoid sinuses. The lesion demonstrated heterogeneous T1 and T2 signal, contrast enhancement, and diffusion restriction.

Pathology

Histopathologic examination established the diagnosis of sinonasal melanoma.

Clinical Question

The central radiologic question was not simply whether a sinonasal mass was present. The important task was to determine its origin, pattern of extension, tissue characteristics, and imaging features supporting an aggressive neoplasm.

MRI Analysis: Reading the Tumor as a Pattern

Figure 1. Axial T1-weighted MRI demonstrating a left nasal cavity-centered soft-tissue mass.

Radiologist Interpretation:
The lesion is centered in the left nasal cavity and demonstrates heterogeneous signal with areas of relatively increased T1 signal compared with surrounding soft tissue. The mass extends posteriorly and laterally toward the paranasal sinuses.

Clinical Significance:
T1 hyperintensity within a sinonasal mass raises the possibility of melanin, although hemorrhage, fat, and proteinaceous material must also be considered.

ALT Text:
Axial T1-weighted MRI showing a heterogeneous left nasal cavity mass with relatively high T1 signal.

Why Is the Lesion Bright on T1?

This is arguably the most important imaging physics question in this case.

Melanin has paramagnetic properties. Its interaction with the local magnetic environment can shorten T1 relaxation, resulting in increased signal intensity on T1-weighted images.

Conceptually:

Melanin → paramagnetic effect → T1 shortening → T1 hyperintensity

This relationship is one of the classic imaging clues of melanotic melanoma.

However, the radiologist must resist the temptation to treat T1 hyperintensity as a diagnosis.

T1 hyperintensity has a broader differential.

Cause of T1 Hyperintensity	Relevant Imaging Clue
Melanin	May occur in melanotic melanoma
Subacute hemorrhage	Methemoglobin can produce T1 shortening
Fat	Suppresses on fat-saturated sequences
Proteinaceous material	May be seen in certain secretions
Other paramagnetic substances	Less common

Therefore, the correct question is not:

"Is the lesion bright on T1?"

It is:

"Why is this lesion bright on T1?"

That distinction is fundamental to high-quality MRI interpretation.

T2-Weighted MRI: A Useful but Imperfect Companion

Figure 2. Axial T2-weighted MRI demonstrating heterogeneous signal within the sinonasal mass.

Radiologist Interpretation:
The mass occupies portions of the left nasal cavity and adjacent paranasal sinuses and demonstrates heterogeneous T2 signal intensity.

Clinical Significance:
T2 signal can vary according to melanin content, hemorrhage, cellularity, necrosis, and other histologic components. A relatively low T2 signal may support a melanotic component, but this is not universal.

ALT Text:
Axial T2-weighted MRI showing a heterogeneous sinonasal mass involving the left nasal cavity and paranasal sinuses.

A classic melanotic melanoma pattern may include T1 hyperintensity and relative T2 hypointensity.

But this pattern should never be treated as mandatory.

Amelanotic melanoma may demonstrate much less characteristic signal behavior. Therefore:

T1 high + T2 low = useful clue, not diagnostic criterion.

This distinction becomes especially important when evaluating tumors that do not contain substantial melanin.

Contrast-Enhanced MRI: Mapping the Tumor

Figure 3. Axial contrast-enhanced T1-weighted MRI demonstrating enhancement of the sinonasal mass.

Radiologist Interpretation:
The left nasal cavity and sinonasal mass demonstrate substantial enhancement with heterogeneous internal characteristics.

Clinical Significance:
Post-contrast MRI helps define tumor extent, distinguish tumor from adjacent mucosal disease, and evaluate possible extension toward the orbit, skull base, and other critical structures. Comparison with the precontrast T1-weighted sequence is particularly important when intrinsic T1 hyperintensity is present.

ALT Text:
Axial contrast-enhanced T1-weighted MRI demonstrating enhancement of a left sinonasal mass.

Intrinsic T1 hyperintensity creates a practical interpretive problem.

If a lesion is already bright before contrast administration, simply looking at the post-contrast image may make enhancement difficult to appreciate visually.

This is why subtraction imaging, when available and technically reliable, can be useful in selected cases.

The radiologist should compare:

Precontrast T1 → Postcontrast T1 → Enhancement pattern

rather than interpreting the postcontrast sequence in isolation.

Coronal MRI: The Importance of the Second Plane

Figure 4. Coronal contrast-enhanced T1-weighted MRI demonstrating superior-inferior tumor extension.

Radiologist Interpretation:
The coronal plane demonstrates extension of the mass from the left nasal cavity toward the ethmoid and maxillary sinus regions.

Clinical Significance:
Coronal imaging is particularly valuable for assessing the relationship of sinonasal tumors to the orbital medial wall, skull base, ethmoid complex, nasal roof, and adjacent compartments.

Axial images provide excellent information about anterior-posterior and lateral relationships, but coronal imaging can make superior-inferior extension much easier to appreciate.

For surgical planning, multiplanar evaluation is therefore essential.

A practical checklist includes:

Orbital medial wall
Ethmoid roof
Skull base
Nasal septum
Nasopharynx
Pterygopalatine fossa
Perineural pathways
Adjacent soft tissues

The important issue is not merely the size of the mass.

The critical question is where the mass has gone.

DWI and ADC: Confirming True Diffusion Restriction

Figure 5. Axial diffusion-weighted MRI demonstrating high signal within the sinonasal mass.

Radiologist Interpretation:
The lesion demonstrates high signal on DWI, consistent with restricted diffusion in the appropriate context.

Clinical Significance:
Restricted diffusion may reflect increased cellularity and reduced extracellular space. DWI can add diagnostic information when combined with conventional MRI findings.

Figure 6. ADC map demonstrating corresponding low ADC signal within the lesion.

Radiologist Interpretation:
The areas of DWI hyperintensity correspond to relatively low signal on the ADC map, supporting true diffusion restriction.

Clinical Significance:
DWI hyperintensity alone is insufficient because T2 shine-through can mimic restricted diffusion. Corresponding ADC reduction provides stronger evidence of true diffusion restriction.

This is one of the most important practical lessons in diffusion MRI:

Bright DWI does not automatically mean restricted diffusion.

The radiologist should look for:

DWI high signal + ADC low signal

When both findings are present, genuine restriction becomes much more likely.

A 2023 study specifically evaluating sinonasal malignant melanoma versus sinonasal squamous cell carcinoma found that combining conventional MRI characteristics with DWI and ADC measurements can improve diagnostic discrimination. The study reported lower ADC values in sinonasal malignant melanoma and demonstrated that a combined imaging model provided useful diagnostic performance.

Importantly, these findings should support—not replace—pathologic diagnosis.

Imaging Physics: Why Melanin Changes MRI Appearance

MRI signal is a physical consequence of tissue composition and relaxation behavior.

Melanin contains stable free radicals and exhibits paramagnetic properties. These characteristics can influence proton relaxation and shorten T1 relaxation time.

Therefore, increased melanin concentration can contribute to:

T1 hyperintensity
Relative T2 signal reduction in some lesions

But a real tumor is not composed exclusively of melanin.

It may contain:

Melanin
Tumor cells
Hemorrhage
Necrosis
Fibrous tissue
Mucus
Proteinaceous material

The resulting MRI appearance can therefore be heterogeneous.

This explains why sinonasal melanoma should be interpreted as a multicomponent biological lesion, rather than as a simple "T1-bright tumor."

Differential Diagnosis

Several lesions can mimic sinonasal melanoma.

1. Sinonasal Squamous Cell Carcinoma

Squamous cell carcinoma is one of the most important differentials.

Both melanoma and squamous cell carcinoma may produce:

Nasal obstruction
Epistaxis
Soft-tissue mass
Enhancement
Diffusion restriction
Bone destruction

The presence of intrinsic T1 hyperintensity may favor melanotic melanoma, but it is not specific.

Recent MRI research suggests that lesion location, T1 characteristics, T2 morphology, orbital or pterygopalatine involvement, and ADC values can be integrated to improve discrimination between melanoma and squamous cell carcinoma.

2. Esthesioneuroblastoma

Esthesioneuroblastoma often arises near the superior nasal cavity and olfactory region.

Location is therefore an important clue.

The radiologist should assess:

Site of epicenter
Cribriform plate
Olfactory fossa
Skull base
Intracranial extension
Enhancement pattern

3. Sinonasal Lymphoma

Lymphoma may appear as a relatively homogeneous soft-tissue mass.

Compared with some aggressive carcinomas, bone destruction may be less dramatic relative to tumor volume.

The imaging pattern must nevertheless be interpreted with clinical and pathologic information.

Differential Diagnosis Table

Diagnosis	Key Imaging Features	Important Differentiating Point
Sinonasal melanoma	Possible T1 hyperintensity, variable T2 signal, enhancement, diffusion restriction	Melanin-related signal characteristics
Squamous cell carcinoma	Soft-tissue mass, enhancement, diffusion restriction, frequent bone destruction	Usually lacks characteristic intrinsic T1 hyperintensity
Esthesioneuroblastoma	Superior nasal cavity/olfactory region mass	Epicenter near olfactory region
Lymphoma	Often relatively homogeneous soft-tissue mass	Bone may be relatively preserved despite tumor bulk
Inflammatory disease	Mucosal thickening, secretions, inflammatory changes	Usually lacks an aggressive solid mass pattern

No single imaging feature should be used in isolation.

CT Versus MRI: Complementary, Not Competing

Although MRI is central to the characterization of this case, CT remains indispensable.

CT is particularly useful for:

Bone destruction
Sinonasal bony anatomy
Orbital walls
Skull base
Maxillary sinus walls
Calcification
Surgical anatomy

MRI is particularly useful for:

Soft-tissue extent
Bone marrow involvement
Orbital soft-tissue invasion
Skull base involvement
Perineural spread
Vascular and soft-tissue relationships
Melanin-related signal characteristics
DWI/ADC
Residual or recurrent tumor

A practical summary is:

CT answers: "What has happened to the bone?"

MRI answers: "What has happened to the soft tissue and tumor compartments?"

For a complex sinonasal malignancy, these questions are complementary.

Multimodal Imaging Comparison

Modality	Strength	Limitation	Best Clinical Question
CT	Bone and high-resolution anatomy	Less soft-tissue contrast	Is there bone destruction?
MRI	Soft-tissue contrast and tumor extent	Longer examination, motion sensitivity	How far has the tumor extended?
DWI/ADC	Cellular diffusion characteristics	Susceptible to artifacts and T2 shine-through	Is there true diffusion restriction?
Contrast-enhanced MRI	Tumor enhancement and extent	Requires contrast in appropriate patients	Which structures are involved?
Endoscopy	Direct mucosal visualization	Limited deep extension assessment	Where is the mucosal lesion?
Histopathology	Definitive diagnosis	Requires tissue acquisition	What is the tumor?

Clinical Diagnostic Algorithm

Pathophysiology

Sinonasal melanoma arises from melanocytes within the mucosal lining of the sinonasal tract.

Unlike cutaneous melanoma, mucosal melanoma is not primarily driven by ultraviolet exposure.

Mucosal melanomas also exhibit biological and molecular characteristics that differ from conventional cutaneous melanoma. Reviews describe relatively low tumor mutational burden and genomic alterations characterized by structural variants, deletions, and amplifications.

These biological differences matter because therapeutic responses observed in cutaneous melanoma cannot automatically be extrapolated to sinonasal mucosal melanoma.

The tumor's biology is one reason why a multidisciplinary approach is necessary.

Epidemiology and Clinical Presentation

Sinonasal mucosal melanoma is rare and aggressive.

Patients often present with nonspecific symptoms, including:

Nasal obstruction
Epistaxis
Nasal discharge
Reduced sense of smell
Facial pain
Facial pressure
Visible nasal mass

As the tumor progresses, symptoms may reflect invasion of neighboring structures, including the orbit or skull base. Distant metastatic disease may involve organs such as the lungs, liver, bones, brain, skin, kidneys, and adrenal glands.

The clinical challenge is obvious: the early symptoms overlap substantially with common benign sinonasal disorders.

That is precisely why imaging recognition matters.

Treatment Strategy

Treatment should be individualized according to tumor extent, resectability, nodal or distant disease, patient factors, and multidisciplinary assessment.

Surgery

For resectable localized disease, surgery remains a central component of treatment.

The anatomical complexity of the sinonasal region makes achieving an adequate resection challenging. The relationship between the tumor and the orbit, skull base, neurovascular structures, and other critical anatomy must therefore be assessed carefully before surgery.

Radiation Therapy

Postoperative radiation therapy may be considered for local or regional control depending on the clinical situation.

However, the presence of postoperative radiation therapy in a treatment pathway should not be interpreted as proof of an identical overall-survival benefit in every patient.

The evidence base includes retrospective studies and heterogeneous patient populations, and treatment decisions remain individualized.

Systemic and Immune Therapy

For recurrent or metastatic disease, systemic therapy—including immune checkpoint inhibition—has become an important therapeutic consideration.

A 2024 systematic review identified 42 studies addressing immunotherapy and molecular characteristics in sinonasal mucosal melanoma. The review also summarized reported alterations involving BRAF, NRAS, and KIT, emphasizing the biological heterogeneity of this disease.

The 2026 REFCOR guideline publication provides contemporary multidisciplinary guidance for diagnosis, treatment, and follow-up of sinonasal mucosal melanoma.

Treatment should therefore be discussed by an appropriate multidisciplinary team rather than determined from imaging alone.

Prognosis

Sinonasal mucosal melanoma has an unfavorable prognosis compared with many other sinonasal malignancies.

The major contributors include:

Delayed recognition
Advanced local disease at presentation
Anatomical proximity to critical structures
High risk of recurrence
Risk of distant metastasis

Recent systematic reviews and meta-analyses continue to demonstrate poor long-term survival, although reported estimates vary among cohorts and study designs.

The important clinical message is not a single survival percentage.

It is that early recognition, accurate local staging, complete multidisciplinary assessment, and appropriate systemic evaluation are central to management.

Artificial Intelligence Perspective

Sinonasal melanoma provides an interesting challenge for medical AI.

At first glance, it may appear to be a straightforward computer-vision problem: identify a sinonasal mass and classify it.

In reality, the problem is considerably more difficult.

A clinically useful AI system would need to integrate:

Anatomical location
T1 signal
T2 characteristics
Contrast enhancement
DWI
ADC
Bone destruction
Orbital involvement
Skull base involvement
Perineural spread
Clinical presentation

This is a multimodal reasoning problem rather than simple image classification.

AI Workflow for Sinonasal Tumor Assessment

The AI should function as a decision-support component rather than an autonomous diagnostic authority.

What Could AI Actually Detect?

A future system might assist with:

1. Tumor Localization

Identify suspicious soft-tissue abnormalities in the nasal cavity and paranasal sinuses.

2. Segmentation

Estimate tumor volume and identify anatomical compartments involved.

3. Multisequence Analysis

Analyze T1, T2, contrast-enhanced imaging, DWI, and ADC together.

4. Bone Invasion Assessment

Integrate CT information with MRI findings.

5. Orbital and Skull Base Assessment

Flag possible invasion of critical structures.

6. Differential Diagnosis Support

Estimate the likelihood of melanoma, squamous cell carcinoma, lymphoma, or other entities.

7. Structured Reporting

Automatically populate relevant anatomical fields for radiologist verification.

The goal should not be to replace the radiologist.

The goal should be to reduce omission, improve consistency, and help the radiologist focus attention on clinically important abnormalities.

AI Failure Modes

A medical AI system can fail in several ways.

False Negative

A small tumor may be missed, particularly if it resembles inflammatory mucosal disease.

False Positive

Secretions, inflammatory changes, postoperative changes, or benign masses may be incorrectly flagged as malignancy.

Domain Shift

A model trained predominantly on one scanner vendor, field strength, acquisition protocol, or patient population may perform differently in another institution.

Amelanotic Melanoma

A model relying too heavily on T1 hyperintensity may fail when the tumor lacks a classic melanotic MRI phenotype.

Hemorrhage

Hemorrhagic lesions can produce T1 hyperintensity and may mimic a melanotic tumor.

DWI Artifact

Distortion and susceptibility effects near the skull base can degrade diffusion imaging.

Workflow Failure

An accurate model may still have limited clinical value if its output is poorly integrated into PACS or the radiologist's workflow.

This is why AI validation must extend beyond model accuracy.

Explainability: Why "T1 Bright" Is Not Enough

An AI model that simply outputs:

"Sinonasal melanoma: 92%"

is not necessarily clinically useful.

A more meaningful system might indicate:

Suspicious mass localized to left nasal cavity
Intrinsic T1 hyperintensity
Heterogeneous T2 signal
Contrast enhancement
DWI hyperintensity
Low ADC
Extension into ethmoid and maxillary sinus regions
Possible differential: melanotic melanoma versus other hyperintense sinonasal lesion

Such an output gives the radiologist something to verify.

But even an interpretable model can be wrong.

Heat maps, saliency maps, confidence scores, and feature attribution do not guarantee diagnostic correctness.

Explainability is not equivalent to reliability.

Enterprise Healthcare Workflow

At hospital scale, a sinonasal AI model would need to fit into the existing enterprise imaging ecosystem.

A highly accurate algorithm that produces results outside the radiologist's workflow may have less clinical value than a moderately complex model that integrates seamlessly into PACS and reporting.

Enterprise AI Governance

Before deployment, the hospital should evaluate:

Dataset representativeness
External validation
Scanner diversity
Protocol variation
Image quality
False-positive burden
False-negative risk
Calibration
Workflow latency
PACS interoperability
Audit logging
Cybersecurity
Model versioning
Drift detection
Revalidation

A model that performs well during development may degrade after deployment because the clinical environment changes.

New scanners are introduced.

MRI protocols change.

Patient populations change.

Radiologists change workflows.

Therefore:

Deployment is not the end of AI validation. It is the beginning of AI lifecycle governance.

Ten Expert Insights

Expert Insight 1 — Radiologist Perspective

The most important MRI clue may be the relationship between T1 signal and lesion location. T1 hyperintensity should immediately trigger a structured differential rather than an automatic melanoma diagnosis.

Expert Insight 2 — Anatomy Perspective

Tumor extension is often more clinically important than tumor diameter. Orbital, skull base, perineural, and neurovascular relationships can substantially influence management.

Expert Insight 3 — MRI Physics Perspective

Melanin-related T1 shortening is a biological imaging signature, but the same MRI appearance can arise from other substances. Signal interpretation must therefore remain mechanism-based.

Expert Insight 4 — Diffusion Perspective

DWI should never be interpreted without the ADC map when the question is true diffusion restriction.

Expert Insight 5 — Differential Diagnosis Perspective

Melanoma and squamous cell carcinoma can share many aggressive imaging characteristics. Their distinction requires integration of morphology, location, signal characteristics, diffusion, and pathology.

Expert Insight 6 — CT Perspective

MRI should not replace CT for assessment of sinonasal bone destruction and surgical anatomy.

Expert Insight 7 — Surgical Perspective

The radiology report should explicitly describe the relationship between tumor and structures that may affect resection, especially the orbit and skull base.

Expert Insight 8 — AI Deployment Perspective

A melanoma AI model trained exclusively on classic T1-hyperintense tumors could fail disproportionately on amelanotic lesions.

Expert Insight 9 — Enterprise IT Perspective

The clinical value of AI depends on integration with DICOM, PACS, RIS, reporting, and EMR workflows—not merely algorithmic performance.

Expert Insight 10 — Patient Journey Perspective

The initial symptom may appear trivial, but persistent unilateral symptoms can become the starting point of a much more serious diagnostic pathway.

Clinical Pearls

Persistent unilateral nasal obstruction deserves careful clinical attention.
Recurrent epistaxis accompanying a nasal mass should not automatically be attributed to inflammation.
T1 hyperintensity within a sinonasal mass is a major clue but is not specific for melanoma.
Melanin can shorten T1 relaxation and increase T1 signal.
Melanotic and amelanotic melanomas can have different MRI appearances.
T2 signal should be interpreted together with T1 characteristics.
Precontrast and postcontrast T1 images should be compared carefully.
DWI hyperintensity requires ADC correlation.
CT and MRI provide complementary information.
Coronal imaging is important for superior-inferior extension.
Orbital and skull base involvement should be actively assessed.
Imaging can strongly suggest melanoma but cannot replace pathology.
Treatment planning should be multidisciplinary.
Recurrent and metastatic disease may require systemic therapy.
AI should support radiologist reasoning rather than replace it.

Common Diagnostic Pitfalls

Pitfall 1: Assuming every unilateral nasal mass is inflammatory

A persistent unilateral mass requires a broader differential diagnosis.

Pitfall 2: Calling every T1-bright lesion melanoma

Hemorrhage, fat, and proteinaceous material can also be T1 hyperintense.

Pitfall 3: Excluding melanoma because T2 is not dark

Not every melanoma exhibits the classic T1-high/T2-low pattern.

Pitfall 4: Interpreting DWI without ADC

T2 shine-through can mimic restricted diffusion.

Pitfall 5: Evaluating only axial images

Coronal and other multiplanar sequences may reveal clinically important extension.

Pitfall 6: Ignoring bone anatomy

MRI is excellent for soft tissue but CT remains important for osseous assessment.

Pitfall 7: Diagnosing melanoma solely from imaging

Histopathologic confirmation remains necessary.

Pitfall 8: Reporting only tumor size

Tumor relationships to critical anatomical structures may be more important than maximum diameter.

Pitfall 9: Overtrusting AI

AI may fail because of domain shift, atypical tumor phenotype, image artifacts, or workflow limitations.

Pitfall 10: Treating AI output as a final diagnosis

AI-generated predictions require clinical and radiologic verification.

Frequently Asked Questions

What is sinonasal melanoma?

Sinonasal melanoma is a rare malignant melanoma arising in the mucosal surfaces of the nasal cavity and paranasal sinus region. It is clinically important because symptoms can be nonspecific and the tumor may be diagnosed at an advanced stage.

What is the key MRI finding?

The classic imaging clue is intrinsic T1 hyperintensity within a sinonasal mass, particularly when a melanotic component is present. However, T1 hyperintensity is not specific for melanoma.

Why is melanoma bright on T1?

Melanin has paramagnetic properties that can shorten T1 relaxation, producing increased signal on T1-weighted MRI.

Is T2 hypointensity required?

No. T2 signal is variable, and amelanotic melanoma may not show the classic signal pattern.

Does diffusion restriction occur?

It can. DWI hyperintensity with corresponding low ADC supports true diffusion restriction.

Can MRI diagnose sinonasal melanoma?

MRI can strongly suggest the diagnosis and define tumor extent, but definitive diagnosis requires tissue pathology.

Is CT still necessary?

Yes. CT is particularly valuable for bone destruction, sinonasal anatomy, and surgical planning.

What is the major differential diagnosis?

Sinonasal squamous cell carcinoma is an important differential, along with esthesioneuroblastoma, lymphoma, and other sinonasal masses.

Is surgery important?

For appropriately selected resectable localized disease, surgery remains a central treatment modality.

Can immunotherapy be used?

Systemic immunotherapy is an important consideration, particularly in recurrent or metastatic disease, although treatment decisions depend on individual disease characteristics and multidisciplinary assessment.

Quiz

Question 1

A 50-year-old man presents with persistent unilateral nasal obstruction. MRI demonstrates a sinonasal mass with intrinsic T1 hyperintensity, DWI hyperintensity, and corresponding low ADC. Which diagnosis should be strongly considered?

① Nasal polyp
② Chronic sinusitis
③ Sinonasal melanoma
④ Simple retention cyst
⑤ Uncomplicated allergic rhinitis

Correct Answer: ③ Sinonasal melanoma

Explanation: Intrinsic T1 hyperintensity can reflect melanin, while DWI hyperintensity with low ADC supports true diffusion restriction. The combination should raise strong suspicion for an aggressive sinonasal neoplasm.

Question 2

Which statement about T1 hyperintensity in sinonasal melanoma is most accurate?

① All sinonasal melanomas are T1 hyperintense.
② T1 hyperintensity excludes hemorrhage.
③ Melanin can cause T1 hyperintensity.
④ T1 hyperintensity proves melanoma.
⑤ Amelanotic melanoma always demonstrates T1 hyperintensity.

Correct Answer: ③ Melanin can cause T1 hyperintensity

Explanation: Melanin may shorten T1 relaxation and produce high T1 signal, but the finding is neither universal nor specific.

Question 3

Which combination provides the strongest evidence of true diffusion restriction?

① DWI low + ADC high
② DWI high + ADC high
③ DWI high + ADC low
④ DWI low + ADC low
⑤ DWI absent + ADC high

Correct Answer: ③ DWI high + ADC low

Explanation: Corresponding ADC reduction supports true restriction and helps distinguish it from T2 shine-through.

Question 4

Which imaging modality is particularly valuable for evaluating sinonasal bone destruction?

① CT
② DWI only
③ Ultrasound
④ Plain chest radiography
⑤ PET alone

Correct Answer: ① CT

Explanation: CT provides high-resolution assessment of the sinonasal skeleton, orbital walls, skull base, and other bony structures.

Question 5

Which statement is most appropriate regarding imaging diagnosis?

① MRI eliminates the need for biopsy.
② T1 hyperintensity alone confirms melanoma.
③ DWI alone establishes the diagnosis.
④ Imaging supports diagnosis and staging, but histopathology is required for definitive diagnosis.
⑤ CT is unnecessary when MRI is performed.

Correct Answer: ④ Imaging supports diagnosis and staging, but histopathology is required for definitive diagnosis.

Explanation: Imaging provides essential diagnostic and staging information, but tissue diagnosis remains necessary.

Key Takeaways

Sinonasal melanoma is rare, but its imaging phenotype can be highly informative.

The central lessons from this case are:

Persistent unilateral nasal symptoms deserve attention.

A sinonasal mass with T1 hyperintensity should trigger consideration of melanin—but also hemorrhage, fat, and proteinaceous material.

T1 and T2 signal must be interpreted together.

Contrast-enhanced MRI defines tumor extent and critical anatomical relationships.

DWI should always be correlated with ADC.

CT and MRI are complementary.

Amelanotic melanoma can lack the classic MRI appearance.

Imaging cannot replace histopathology.

Treatment requires multidisciplinary decision-making.

And perhaps the most useful question for the radiologist is deceptively simple:

Why is this lesion bright on T1?

That question transforms an imaging observation into clinical reasoning.

Conclusion

Sinonasal melanoma presents a difficult diagnostic problem because its symptoms can initially resemble common benign sinonasal disorders. Persistent unilateral nasal obstruction, recurrent epistaxis, or a visible nasal mass should therefore be interpreted in the context of the patient's age, symptom persistence, physical examination, and imaging findings.

MRI provides particularly valuable information because it can characterize the tumor's soft-tissue extent and demonstrate biological clues that may reflect its composition.

In the present case, the combination of a left nasal cavity-centered mass, heterogeneous T1 and T2 signal, enhancement, diffusion restriction, and extension into adjacent paranasal sinuses created a coherent radiologic pattern that supported consideration of sinonasal melanoma. The characteristic T1 hyperintensity is particularly important because it may reflect melanin-related T1 shortening. Nevertheless, this feature is not universal and is not specific.

The radiologist should therefore avoid a one-sequence diagnosis.

The most reliable approach is a structured synthesis:

Clinical symptoms → anatomical epicenter → T1/T2 characteristics → enhancement → DWI/ADC → local extension → CT correlation → pathology

This approach is useful not only for sinonasal melanoma but also as a general model for interpreting uncommon head and neck malignancies.

The final lesson is simple:

Do not merely identify the mass. Explain why it looks the way it does, where it has spread, what it could be, and what the clinical team needs to know next.

References

[1] D. M. Yousem, C. Li, K. T. Montone, et al., “Primary malignant melanoma of the sinonasal cavity: MR imaging evaluation,” RadioGraphics, vol. 16, no. 5, pp. 1101–1110, 1996, doi: 10.1148/radiographics.16.5.8888393.

[2] I. S. Alves, L. G. Berriel, R. T. Alves, et al., “Sinonasal melanoma: A case report and literature review,” Case Reports in Oncological Medicine, 2017, Art. no. 8201301, doi: 10.1155/2017/8201301.

[3] T. Wang, Y. Huang, J. Lu, and M. Xiang, “Sinonasal mucosal melanoma: A 10-year experience of 36 cases in China,” Annals of Translational Medicine, vol. 8, no. 16, p. 1022, 2020, doi: 10.21037/atm-20-5575.

[4] M. R. Gore and A. M. Zanation, “Survival in sinonasal melanoma: A meta-analysis,” Otolaryngology–Head and Neck Surgery, 2012, doi: 10.1055/s-0032-1301400.

[5] F. S. Pontes, L. L. de Souza, M. C. de Abreu, et al., “Sinonasal melanoma: A systematic review of the prognostic factors,” International Journal of Oral and Maxillofacial Surgery, vol. 49, no. 5, pp. 549–557, 2020, doi: 10.1016/j.ijom.2019.11.001.

[6] M. C. Crippen, S. Kılıç, and J. A. Eloy, “Updates in the management of sinonasal mucosal melanoma,” Current Opinion in Otolaryngology & Head and Neck Surgery, vol. 26, no. 1, pp. 52–57, 2018, doi: 10.1097/MOO.0000000000000428.

[7] R. K. Foreman and L. M. Duncan, “Sinonasal mucosal melanoma: A contemporary review,” Surgical Pathology Clinics, vol. 17, no. 4, pp. 667–682, 2024, doi: 10.1016/j.path.2024.07.006.

[8] H. Liu, X. Wang, M. Su, et al., “Differentiating sinonasal malignant melanoma from squamous cell carcinoma using DWI combined with conventional MRI,” Neuroradiology, vol. 65, no. 8, pp. 1263–1270, 2023, doi: 10.1007/s00234-023-03164-3.

[9] Y.-K. Kim, J. W. Choi, H.-J. Kim, et al., “Melanoma of the sinonasal tract: Value of a septate pattern on precontrast T1-weighted MR imaging,” American Journal of Neuroradiology, vol. 39, no. 4, pp. 762–767, 2018, doi: 10.3174/ajnr.A5539.

[10] M. Amit, S. Na’ara, and E. Y. Hanna, “Contemporary treatment approaches to sinonasal mucosal melanoma,” Current Oncology Reports, vol. 20, no. 2, Art. no. 10, 2018, doi: 10.1007/s11912-018-0660-7.

[11] M. J. Rojas-Lechuga, S. Jubés, M. Molina-García, et al., “Survival outcomes in sinonasal mucosal melanoma: Systematic review and meta-analysis,” Journal of Personalized Medicine, vol. 14, no. 12, p. 1120, 2024, doi: 10.3390/jpm14121120.

[12] A. Tang, S. Taori, S. Dang, et al., “Immunotherapy in the management of sinonasal mucosal melanoma: A systematic review,” Otolaryngology–Head and Neck Surgery, vol. 171, no. 2, pp. 368–380, 2024, doi: 10.1002/ohn.790.

[13] E. M. Iyoha, S. M. Jenkins, R. Guo, and G. Choby, “Outcomes of immunotherapy in sinonasal mucosal melanoma patients with recurrent and metastatic disease,” Otolaryngology–Head and Neck Surgery, vol. 171, no. 4, pp. 1245–1249, 2024, doi: 10.1002/ohn.850.

[14] A. Moya-Plana, M. Khalaf, O. Casiraghi, et al., “Sinonasal mucosal melanoma: REFCOR guidelines for diagnosis, treatment and follow-up,” European Annals of Otorhinolaryngology, Head and Neck Diseases, vol. 143, no. 3, pp. 207–211, 2026, doi: 10.1016/j.anorl.2026.04.004.

[15] A. J. Orr, R. Fenberg, R. L. Carrau, et al., “Sinonasal mucosal melanoma survival outcomes, recurrence patterns, and prognostic factors: A systematic literature review and meta-analysis of publications after 2000,” European Archives of Oto-Rhino-Laryngology, vol. 281, no. 6, pp. 694–705, 2024, doi: 10.1055/a-2437-7837.

[16] D. Kim and S.-N. Hong, “Sinonasal mucosal melanoma: A comprehensive review and clinical experience,” Journal of Rhinology, vol. 32, no. 3, pp. 123–132, 2025, doi: 10.18787/jr.2025.00042.

Medical Disclaimer

This article is provided for educational and informational purposes only. It does not replace professional medical diagnosis, treatment, or individualized clinical advice. Patients with persistent unilateral nasal obstruction, recurrent epistaxis, a nasal mass, or other concerning symptoms should undergo appropriate evaluation by a qualified healthcare professional.

Sinonasal Melanoma on MRI: When Unilateral Nasal Obstruction Reveals an Aggressive Mucosal Malignancy